WILLIAM K PLUNKETT JR to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications WILLIAM K PLUNKETT JR has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.029
-
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia. J Clin Pharmacol. 2004 Nov; 44(11):1309-22.
Score: 0.012
-
The expanding role of fludarabine in hematologic malignancies. Leuk Lymphoma. 1994; 14 Suppl 2:11-6.
Score: 0.011
-
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma. Ann Oncol. 1994; 5 Suppl 2:79-83.
Score: 0.006